Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
Tirzepatide tends to cause fewer gastrointestinal side effects (nausea and vomiting) compared to Semaglutide, despite showing more significant weight loss over time
PlexusDx oral tirzepatide is available to all 50 states without insurance requirements or membership fees, at $349/mo month-to-month, or from $279/mo on the 6-month plan flat
May 17, 2023
Yes, Semaglutide is FDA-approved and has been extensively studied for both weight management and diabetes treatment
It is not in any active US new drug application pipeline
Eligible patients may qualify for telehealth wellness consultations
US$ 20.67
US$ 24.42
US$ 20.51
US$ 24.18
US$ 24.98
US$ 20.23
US$ 25.36
US$ 20.52
US$ 23.44
US$ 25.98
US$ 29.76
US$ 23.53
US$ 28.56
